PURPOSE: The objective of this study was to evaluate the quality of care provided to uninsured women with breast cancer who received treatment through the Breast and Cervical Cancer Prevention Treatment Program (BCCTP). METHODS: Participants included women with stage I to III breast cancer (n = 658) from a consecutive sample of women 18 years or older who received coverage through the California BCCTP between February 2003 and September 2005 who consented to a survey and medical record review (61% response rate). Quality of breast cancer care was evaluated using 29 evidence-based quality measures developed for the National Initiative for Cancer Care Quality (NICCQ). NICCQ, a largely insured cohort of women diagnosed with stage I to III breast cancer in 1998, was used to benchmark the results. RESULTS: Twenty-three percent of women presented with stage III disease compared with fewer than 10% nationally. Patients received 93% of recommended care (95% CI, 92% to 93%). Adherence to recommended care within domains ranged from 87% for post-treatment surveillance (95% CI, 84% to 90%) to 97% for diagnostic evaluation (95% CI, 96% to 97%). Compared to the NICCQ cohort, adherence to quality measures was as good or better for the BCCPT cohort in all domains except post-treatment surveillance. CONCLUSION: The BCCTP has made important inroads in providing poor, uninsured women with access to high quality care when faced with the diagnosis of breast cancer; however, many present at an advanced stage, which is associated with worse outcomes.
PURPOSE: The objective of this study was to evaluate the quality of care provided to uninsured women with breast cancer who received treatment through the Breast and Cervical Cancer Prevention Treatment Program (BCCTP). METHODS:Participants included women with stage I to III breast cancer (n = 658) from a consecutive sample of women 18 years or older who received coverage through the California BCCTP between February 2003 and September 2005 who consented to a survey and medical record review (61% response rate). Quality of breast cancer care was evaluated using 29 evidence-based quality measures developed for the National Initiative for Cancer Care Quality (NICCQ). NICCQ, a largely insured cohort of women diagnosed with stage I to III breast cancer in 1998, was used to benchmark the results. RESULTS: Twenty-three percent of women presented with stage III disease compared with fewer than 10% nationally. Patients received 93% of recommended care (95% CI, 92% to 93%). Adherence to recommended care within domains ranged from 87% for post-treatment surveillance (95% CI, 84% to 90%) to 97% for diagnostic evaluation (95% CI, 96% to 97%). Compared to the NICCQ cohort, adherence to quality measures was as good or better for the BCCPT cohort in all domains except post-treatment surveillance. CONCLUSION: The BCCTP has made important inroads in providing poor, uninsured women with access to high quality care when faced with the diagnosis of breast cancer; however, many present at an advanced stage, which is associated with worse outcomes.
Authors: Eric C Schneider; Jennifer L Malin; Katherine L Kahn; Ezekiel J Emanuel; Arnold M Epstein Journal: J Clin Oncol Date: 2004-08-01 Impact factor: 44.544
Authors: Tenbroeck Smith; Kevin D Stein; C Christina Mehta; Chiewkwei Kaw; James L Kepner; Trent Buskirk; Jeremy Stafford; Frank Baker Journal: Cancer Date: 2007-01-01 Impact factor: 6.860
Authors: A L Potosky; L C Harlan; J L Stanford; F D Gilliland; A S Hamilton; P C Albertsen; J W Eley; J M Liff; D Deapen; R A Stephenson; J Legler; C E Ferrans; J A Talcott; M S Litwin Journal: J Natl Cancer Inst Date: 1999-10-20 Impact factor: 13.506
Authors: Florence K L Tangka; Sujha Subramanian; Madeleine Jones; Patrick Edwards; Timothy Flanigan; Yevgeniya Kaganova; Kevin W Smith; Cheryll C Thomas; Nikki A Hawkins; Juan Rodriguez; Temeika Fairley; Gery P Guy Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-03 Impact factor: 4.254
Authors: Sarah T Hawley; Sarah E Lillie; Arden Morris; John J Graff; Ann Hamilton; Steven J Katz Journal: Ann Surg Oncol Date: 2012-10-06 Impact factor: 5.344
Authors: Jennifer J Griggs; Yihang Liu; Melony E Sorbero; Christina H Jagielski; Rose C Maly Journal: Breast Cancer Res Treat Date: 2014-03-05 Impact factor: 4.872
Authors: Sujha Subramanian; Florence K L Tangka; Patrick Edwards; Madeleine Jones; Tim Flanigan; Jenya Kaganova; Kevin Smith; Cheryll C Thomas; Nikki A Hawkins; Juan L Rodriguez; Gery P Guy; Temeika Fairley Journal: Cancer Causes Control Date: 2020-09-08 Impact factor: 2.506
Authors: Jeffrey Landercasper; Oluwadamilola M Fayanju; Lisa Bailey; Tiffany S Berry; Andrew J Borgert; Robert Buras; Steven L Chen; Amy C Degnim; Joshua Froman; Jennifer Gass; Caprice Greenberg; Starr Koslow Mautner; Helen Krontiras; Luis D Ramirez; Michelle Sowden; Barbara Wexelman; Lee Wilke; Roshni Rao Journal: Ann Surg Oncol Date: 2017-11-22 Impact factor: 5.344
Authors: Rebecca A Nelson; Zeynep Bostanci; Veronica Jones; Joanne Mortimer; Amy Polverini; Lesley Taylor; Lisa Yee; John H Yim; Laura Kruper Journal: Ann Surg Oncol Date: 2020-01-21 Impact factor: 5.344
Authors: Kevin M Gorey; Isaac N Luginaah; Eric J Holowaty; Guangyong Zou; Caroline Hamm; Madhan K Balagurusamy Journal: Int J Equity Health Date: 2013-01-14
Authors: Jeffrey Landercasper; Lisa Bailey; Robert Buras; Ed Clifford; Amy C Degnim; Leila Thanasoulis; Oluwadamilola M Fayanju; Judy A Tjoe; Roshni Rao Journal: Ann Surg Oncol Date: 2017-08-01 Impact factor: 5.344